Esther Cho
General Counsel, Keros Therapeutics, Inc.
Companies
- Keros Therapeutics, Inc.General counsel Aug 15, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Keros Therapeutics, Inc. KROS35,770 shares2$394.9K at $11.04Aug 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 18, 2026Sold 4,485 shares at $10.29 of Keros Therapeutics, Inc.2
- Feb 18, 2026Sold 4,745 shares at $16.35 of Keros Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 20, 2026